Delivery Order SPE2DB24D2010-SPE2DB24FZUY8

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $12,055.95 firm-fixed-price contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a medical product, with a completion date of November 22, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,659.36 firm fixed-price contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a medical product. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,927.28 firm fixed-price delivery order is for the supply of 4559131284 ! YUVAFEM 10 MCG VAGINAL INSERT 18S medical products, with a completion date of November 18, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The award is for $1,688.52 to supply YUVAFEM 10 MCG VAGINAL INSERT 8S, a pharmaceutical product. The contract has a firm fixed-price payment structure and an ultimate completion date of October 15, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,557.97 delivery order contract is for the provision of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. The contract has a completion date of February 12, 2025 and is a firm fixed-price, non-set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,124.28, is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product, to support federal healthcare programs. This is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of YUVAFEM 10 MCG VAGINAL INSERT 8S. The contract is a firm fixed-price delivery order with a ceiling value of $2,855.85 and a performance period running through January 28, 2025. This award is not associated with a set-aside program. Additionally, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order valued at $1,323.48 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a medical product, with a completion date of July 25, 2024. The contract is a firm fixed price arrangement and was not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,546.12 firm fixed-price delivery order is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a medical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,577.93 firm fixed-price contract is for the delivery of 4564996238 YUVAFEM 10 MCG vaginal inserts. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZUY8
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,535.59 firm fixed-price contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 8S, a medical product. The award has no set-aside designation, indicating open competition.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities.

Generated 5/16/25, 12:15 PM